AKT1 and cancer: The RAF/MEK/ERK and PI3K/PTEN/AKT/mTORC1 pathways are central signal transduction pathways that are often activated in human cancers due to various mechanisms, including dysregulation of intrinsic components, as well as, mutations in upstream receptors and other interacting signaling molecules.